Literature DB >> 7901701

Apoptosis in prostate cancer after hormonal treatment.

B Szende, I Romics, L Vass.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7901701     DOI： 10.1016/0140-6736(93)92779-s

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands.

Authors:  Naozumi Ishimaru; Rieko Arakaki; Fumie Omotehara; Koichi Yamada; Kenji Mishima; Ichiro Saito; Yoshio Hayashi
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

2.  Autophagy regulates lipolysis and cell survival through lipid droplet degradation in androgen-sensitive prostate cancer cells.

Authors:  Ramesh R Kaini; Laurel O Sillerud; Siqin Zhaorigetu; Chien-An A Hu
Journal:  Prostate       Date:  2012-01-31       Impact factor: 4.104

3.  Apoptosis in Untreated and Hormone-Treated Prostate Cancer of Various Histological Types.

Authors:  Béla Szende; Thomas Lübben; László Vass
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

4.  Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background.

Authors:  Naozumi Ishimaru; Rieko Arakaki; Megumi Watanabe; Masaru Kobayashi; Katsushi Miyazaki; Yoshio Hayashi
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

5.  Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren's syndrome-like autoimmune exocrinopathy.

Authors:  Naozumi Ishimaru; Rieko Arakaki; Satoko Yoshida; Akiko Yamada; Sumihare Noji; Yoshio Hayashi
Journal:  J Exp Med       Date:  2008-11-17       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.